Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujan Shresta

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Journal of Virology|March 13, 2015
Dengue Virus Evolution under a Host-Targeted AntiviralEmily Plummer, Michael D Buck, Marisa Sanchez, et al.
Mbio|September 17, 2015
Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus InfectionAmelia K Pinto, James D Brien, Chia-Ying Kao Lam, et al.
Plos Pathogens|May 29, 2019
Correction: CD4+ T cells promote humoral immunity and viral control during Zika virus infectionAnnie Elong Ngono, Matthew P Young, Maximilian Bunz, et al.
Plos Pathogens|January 25, 2019
CD4+ T cells promote humoral immunity and viral control during Zika virus infectionAnnie Elong Ngono, Matthew P Young, Maximilian Bunz, et al.
Virology Journal|April 3, 2020
Investigation of the immunogenicity of Zika glycan loopElizabeth A Henderson, Christina C Tam, Luisa W Cheng, et al.
Antiviral Research|July 4, 2013
Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza virusesHui-Wen Chen, Jenna Xiao Cheng, Ming-Tsan Liu, et al.
Viruses|May 19, 2015
A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)Kelly L Warfield, Emily Plummer, Dominic S Alonzi, et al.
Cell Reports|July 24, 2025
Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformationEduardo Olmedillas, Roshan R Rajamanickam, Ruben Diaz Avalos, et al.
NPJ Vaccines|March 25, 2026
A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2Jing Wen, Jaesu Moon, Luca Tucciarone, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
A new mRNA antigen vaccine induces potent B and T cell responses and <i>in vivo</i> protection against SARS-CoV-2Jing Wen, Jaesu Moon, Luca Tucciarone, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Journal of Virology|March 13, 2015
Dengue Virus Evolution under a Host-Targeted AntiviralEmily Plummer, Michael D Buck, Marisa Sanchez, et al.
Mbio|September 17, 2015
Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus InfectionAmelia K Pinto, James D Brien, Chia-Ying Kao Lam, et al.
Plos Pathogens|May 29, 2019
Correction: CD4+ T cells promote humoral immunity and viral control during Zika virus infectionAnnie Elong Ngono, Matthew P Young, Maximilian Bunz, et al.
Plos Pathogens|January 25, 2019
CD4+ T cells promote humoral immunity and viral control during Zika virus infectionAnnie Elong Ngono, Matthew P Young, Maximilian Bunz, et al.
Virology Journal|April 3, 2020
Investigation of the immunogenicity of Zika glycan loopElizabeth A Henderson, Christina C Tam, Luisa W Cheng, et al.
Antiviral Research|July 4, 2013
Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza virusesHui-Wen Chen, Jenna Xiao Cheng, Ming-Tsan Liu, et al.
Viruses|May 19, 2015
A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)Kelly L Warfield, Emily Plummer, Dominic S Alonzi, et al.
Cell Reports|July 24, 2025
Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformationEduardo Olmedillas, Roshan R Rajamanickam, Ruben Diaz Avalos, et al.
NPJ Vaccines|March 25, 2026
A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2Jing Wen, Jaesu Moon, Luca Tucciarone, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
A new mRNA antigen vaccine induces potent B and T cell responses and <i>in vivo</i> protection against SARS-CoV-2Jing Wen, Jaesu Moon, Luca Tucciarone, et al.
Pageof 12